Open Access Case Report DOI: 10.7759/cureus.17356 Review began 06/29/2021 Review ended 08/14/2021 Legionella Coinfection in a Patient With COVID- Published 08/21/2021 © Copyright 2021 19 Pneumonia Subedi et al. This is an open access 1, 2, 3 1, 2, 3, 4 article distributed under the terms of the Yogesh Subedi , Christopher J. Haas Creative Commons Attribution License CC-BY 4.0., which permits unrestricted 1. Medicine, MedStar Union Memorial Hospital, Baltimore, USA 2. Medicine, MedStar Franklin Square Medical Center, use, distribution, and reproduction in any Baltimore, USA 3. Medicine, MedStar Harbor Hospital, Baltimore, USA 4. Medicine, George Washington University medium, provided the original author and School of Medicine and Health Sciences, Washington, DC, USA source are credited. Corresponding author: Yogesh Subedi,
[email protected] Abstract Bacterial superinfection is a well-reported complication of viral pneumonia leading to significantly increased morbidity and mortality. Such superinfections have been reported in patients with pathogenic coronaviruses including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS), but there are scant reports pertaining to superinfection in the context of coronavirus disease 2019 (COVID-19). We report a case of a middle-aged man who presented with worsening shortness of breath in the context of COVID-19 complicated by superimposed Legionella pneumophilia pneumonia. This case serves to highlight the possibility of bacterial superinfections and to be aware of such possibilities when patients are not responding to standard courses of treatment for COVID-19 as quick clinical deterioration is likely to develop. Categories: Internal Medicine, Infectious Disease, Rheumatology Keywords: covid-19, coinfection, legionella, dexamethasone, remdesivir, azithromycin, rheumatoid arthritis Introduction At the end of 2019, a novel coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, China [1].